Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AKBA - Akebia Therapeutics, Inc.
-25.2 M
LAST VALUE
-9.02%
2 YEAR CAGR
-4.75%
5 YEAR CAGR
-4.78%
10 YEAR CAGR